Sientra Inc. buy melinda
Start price
11.10.18
/
50%
€186.17
Target price
16.10.18
€210.17
Performance (%)
12.89%
End price
16.10.18
€210.17
Summary
This prediction ended on 16.10.18 with a price of €210.17. The prediction had a final performance of 12.89%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sientra Inc. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
Comments by melinda for this prediction
In the thread Sientra Inc. diskutieren
SecteurEquipement, fournitures et distribution médicale Agenda 21/11 Publication de résultats
Develops and commercializes plastic surgery implantable devices
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices.
Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.
The company was founded by Hani M. Zeini in 2006 and is headquartered in Santa Barbara, CA.
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices.
Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.
The company was founded by Hani M. Zeini in 2006 and is headquartered in Santa Barbara, CA.
Nombre d'employés : 200 personnes.